Drug recall · November 15, 2023
Clinical TREAT Antifungal Powder recall
Why: CGMP deviations: the product was shipped from the Manufacturer to a Medline warehouse and released to stock while it was still under investigation for low assay results on the active ingredient miconazole nitrate.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clinical TREAT Antifungal Powder, Vanilla Scent, 3 OZ (85 g) tube, Active Ingredient: Miconazole Nitrate 2.0% w/w Antifungal, Manufactured for Medline Industries, LP, Three Lakes Drive, Northfield, IL 60093 USA, NDC: 53329-169-79
- Lots / codes
Lot 007782, Exp 08/31/2024
- Company
- MEDLINE INDUSTRIES, LP - Northfield, Northfield, IL
- Distribution
- Nationwide
- Initiated
- October 4, 2023 · Voluntary: Firm initiated
- Classified
- November 7, 2023
- Reported
- November 15, 2023
- Ended
- September 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Miconazole
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.